Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Medical Condition: Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Moderately+to+Severely+Active+Crohn%E2%80%99s+Disease+MedDRA+version%3A+20.0Level%3A+PTClassification+code+10011401Term%3A+Crohn%27s+diseaseSystem+Organ+Class%3A+10017947+-+Gastrointestinal+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Digestive+System+Diseases+%5BC06%5D%22
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Moderately+to+Severely+Active+Crohn%E2%80%99s+Disease+MedDRA+version%3A+20.0Level%3A+PTClassification+code+10011401Term%3A+Crohn%27s+diseaseSystem+Organ+Class%3A+10017947+-+Gastrointestinal+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Digestive+System+Diseases+%5BC06%5D%22
Search /vufind/Search2/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Moderately+to+Severely+Active+Crohn%E2%80%99s+Disease+MedDRA+version%3A+20.0Level%3A+PTClassification+code+10011401Term%3A+Crohn%27s+diseaseSystem+Organ+Class%3A+10017947+-+Gastrointestinal+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Digestive+System+Diseases+%5BC06%5D%22
PubPharm (122)
1
Evaluating efficacy and safety of subcutaneous CT-P13 (CT-P13 SC) as maintenance therapy in patients with Crohn's disease : A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Evaluating efficacy and safety of subcutaneous CT-P13 (CT-P13 SC) as maintenance therapy in patients with Crohn's disease : A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Active Crohn’s Disease : Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Active Crohn’s Disease : Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease : A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease : A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Active Crohn’s Disease : Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease : A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease : A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Active Crohn’s Disease : Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Medienart
122
Aufsätze
122
E-Artikel
122
E-Ressourcen
Zeitschriftentitel
122
WHO International Clinical Trials Registry Plat...
Thema
122
610
Medical Condition: Moderately to Severely Activ...
122
Phase: Phase 3
122
Recruitment Status: Authorised-recruitment may ...
122
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
110
2020-
12
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
122
Englisch
Haven't found what you're looking for?
Wird geladen...